| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sterol binding | 2.70e-07 | 71 | 75 | 6 | GO:0032934 | |
| GeneOntologyMolecularFunction | cholesterol binding | 2.56e-06 | 58 | 75 | 5 | GO:0015485 | |
| GeneOntologyMolecularFunction | steroid binding | 1.08e-05 | 133 | 75 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | alcohol binding | 4.10e-05 | 102 | 75 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 6.24e-05 | 57 | 75 | 4 | GO:0120013 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 9.73e-05 | 24 | 75 | 3 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 1.10e-04 | 25 | 75 | 3 | GO:0120015 | |
| GeneOntologyMolecularFunction | lipase binding | 2.89e-04 | 7 | 75 | 2 | GO:0035473 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 3.61e-04 | 37 | 75 | 3 | GO:0000175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 4.55e-04 | 40 | 75 | 3 | GO:0016896 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.13e-04 | 268 | 75 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 6.45e-04 | 45 | 75 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | heparin binding | 7.81e-04 | 192 | 75 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.57e-04 | 196 | 75 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 1.57e-03 | 61 | 75 | 3 | GO:0008408 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.61e-03 | 16 | 75 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.64e-03 | 62 | 75 | 3 | GO:0016796 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.53e-03 | 20 | 75 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.53e-03 | 20 | 75 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.72e-03 | 74 | 75 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 3.52e-03 | 81 | 75 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | lipid binding | OSBPL2 APOA5 MARK1 OSBPL1A OSBPL5 TMEM175 OSBPL6 OSBPL11 APOB PTCH1 | 3.75e-03 | 988 | 75 | 10 | GO:0008289 |
| GeneOntologyBiologicalProcess | lipid transport | OSBPL2 APOA5 LPA OSBPL1A OSBPL5 OSBPL6 OSBPL11 APOB IRS2 PTCH1 NOS2 ABCA7 WNK4 | 3.73e-08 | 506 | 76 | 13 | GO:0006869 |
| GeneOntologyBiologicalProcess | lipid localization | OSBPL2 APOA5 LPA OSBPL1A OSBPL5 OSBPL6 OSBPL11 APOB IRS2 PTCH1 NOS2 ABCA7 WNK4 | 1.34e-07 | 565 | 76 | 13 | GO:0010876 |
| GeneOntologyBiologicalProcess | cholesterol transport | 6.28e-07 | 134 | 76 | 7 | GO:0030301 | |
| GeneOntologyBiologicalProcess | sterol transport | 8.05e-07 | 139 | 76 | 7 | GO:0015918 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 5.14e-05 | 358 | 76 | 8 | GO:0015850 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 8.11e-05 | 194 | 76 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 8.82e-05 | 197 | 76 | 6 | GO:1902904 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 1.33e-04 | 5 | 76 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 1.42e-04 | 215 | 76 | 6 | GO:1905952 | |
| GeneOntologyBiologicalProcess | cholesterol efflux | 1.88e-04 | 77 | 76 | 4 | GO:0033344 | |
| GeneOntologyBiologicalProcess | muscle cell cellular homeostasis | 2.01e-04 | 31 | 76 | 3 | GO:0046716 | |
| GeneOntologyBiologicalProcess | pharyngeal system development | 2.65e-04 | 34 | 76 | 3 | GO:0060037 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 2.78e-04 | 7 | 76 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | parathyroid hormone secretion | 2.78e-04 | 7 | 76 | 2 | GO:0035898 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 3.28e-04 | 89 | 76 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 3.41e-04 | 163 | 76 | 5 | GO:0008203 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 3.70e-04 | 8 | 76 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 3.88e-04 | 93 | 76 | 4 | GO:1903036 | |
| GeneOntologyBiologicalProcess | bile acid biosynthetic process | 4.31e-04 | 40 | 76 | 3 | GO:0006699 | |
| GeneOntologyBiologicalProcess | protein kinase C signaling | 4.63e-04 | 41 | 76 | 3 | GO:0070528 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 4.70e-04 | 376 | 76 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 4.84e-04 | 176 | 76 | 5 | GO:1902652 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 4.97e-04 | 177 | 76 | 5 | GO:0016125 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 5.11e-04 | 100 | 76 | 4 | GO:0043242 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.52e-04 | 29 | 75 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | lipoprotein particle | 5.29e-04 | 44 | 75 | 3 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 5.29e-04 | 44 | 75 | 3 | GO:0034358 | |
| GeneOntologyCellularComponent | protein-lipid complex | 6.42e-04 | 47 | 75 | 3 | GO:0032994 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 8.19e-04 | 12 | 75 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | chylomicron | 9.66e-04 | 13 | 75 | 2 | GO:0042627 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 9.28e-06 | 10 | 61 | 3 | MP:0003434 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.87e-05 | 2 | 61 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.87e-05 | 2 | 61 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.87e-05 | 2 | 61 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.87e-05 | 2 | 61 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.87e-05 | 2 | 61 | 2 | MP:0005035 | |
| MousePheno | absent cornea epithelium | 5.60e-05 | 3 | 61 | 2 | MP:0020856 | |
| MousePheno | choroidal neovascularization | 7.29e-05 | 19 | 61 | 3 | MP:0005546 | |
| MousePheno | increased circulating fibrinogen level | 1.12e-04 | 4 | 61 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.12e-04 | 4 | 61 | 2 | MP:0003305 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | 1.22e-04 | 346 | 61 | 8 | MP:0009763 | |
| MousePheno | abnormal involution of the mammary gland | 1.50e-04 | 24 | 61 | 3 | MP:0006271 | |
| MousePheno | abnormal susceptibility to induced morbidity/mortality | 1.89e-04 | 471 | 61 | 9 | MP:0020148 | |
| MousePheno | abnormal choroid vasculature morphology | 2.15e-04 | 27 | 61 | 3 | MP:0006237 | |
| MousePheno | abnormal mammary gland development | 2.18e-04 | 126 | 61 | 5 | MP:0000628 | |
| MousePheno | abnormal mammary gland growth during lactation | 2.40e-04 | 28 | 61 | 3 | MP:0006270 | |
| MousePheno | gastric ulcer | 2.78e-04 | 6 | 61 | 2 | MP:0003282 | |
| MousePheno | increased IgG2a level | 3.01e-04 | 74 | 61 | 4 | MP:0008500 | |
| MousePheno | hepatic necrosis | 3.86e-04 | 79 | 61 | 4 | MP:0001654 | |
| MousePheno | increased acute phase protein level | 3.88e-04 | 7 | 61 | 2 | MP:0014499 | |
| MousePheno | venoocclusion | 3.88e-04 | 7 | 61 | 2 | MP:0006137 | |
| MousePheno | abnormal conjunctival epithelium morphology | 3.88e-04 | 7 | 61 | 2 | MP:0004481 | |
| MousePheno | peptic ulcer | 3.88e-04 | 7 | 61 | 2 | MP:0003301 | |
| MousePheno | abnormal stomach wall morphology | 4.05e-04 | 80 | 61 | 4 | MP:0010783 | |
| MousePheno | abnormal circulating fibrinogen level | 5.16e-04 | 8 | 61 | 2 | MP:0010213 | |
| MousePheno | decreased keratinocyte migration | 5.16e-04 | 8 | 61 | 2 | MP:0012194 | |
| MousePheno | abnormal gland development | 5.19e-04 | 233 | 61 | 6 | MP:0020973 | |
| MousePheno | decreased susceptibility to neuronal excitotoxicity | 5.53e-04 | 37 | 61 | 3 | MP:0008236 | |
| MousePheno | abnormal mammary gland physiology | 5.82e-04 | 88 | 61 | 4 | MP:0001881 | |
| MousePheno | abnormal apocrine gland physiology | 5.82e-04 | 88 | 61 | 4 | MP:0013555 | |
| Domain | Oxysterol-bd | 6.60e-10 | 12 | 74 | 5 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 6.60e-10 | 12 | 74 | 5 | IPR018494 | |
| Domain | Oxysterol_BP | 6.60e-10 | 12 | 74 | 5 | PF01237 | |
| Domain | OSBP | 6.60e-10 | 12 | 74 | 5 | PS01013 | |
| Domain | Kringle | 3.90e-05 | 17 | 74 | 3 | IPR000001 | |
| Domain | Kringle_CS | 3.90e-05 | 17 | 74 | 3 | IPR018056 | |
| Domain | KRINGLE_2 | 3.90e-05 | 17 | 74 | 3 | PS50070 | |
| Domain | Kringle | 3.90e-05 | 17 | 74 | 3 | PF00051 | |
| Domain | KRINGLE_1 | 3.90e-05 | 17 | 74 | 3 | PS00021 | |
| Domain | KR | 3.90e-05 | 17 | 74 | 3 | SM00130 | |
| Domain | Pentatricopeptide_repeat | 9.99e-05 | 23 | 74 | 3 | IPR002885 | |
| Domain | Kringle-like | 2.73e-04 | 32 | 74 | 3 | IPR013806 | |
| Domain | PH | 8.18e-04 | 278 | 74 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 8.33e-04 | 279 | 74 | 6 | PS50003 | |
| Domain | PH_domain | 8.49e-04 | 280 | 74 | 6 | IPR001849 | |
| Domain | - | 9.01e-04 | 391 | 74 | 7 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.48e-03 | 426 | 74 | 7 | IPR011993 | |
| Domain | PH | 2.15e-03 | 229 | 74 | 5 | PF00169 | |
| Domain | PDZ | 2.38e-03 | 141 | 74 | 4 | PF00595 | |
| Domain | PDZ | 2.83e-03 | 148 | 74 | 4 | SM00228 | |
| Domain | - | 2.97e-03 | 150 | 74 | 4 | 2.30.42.10 | |
| Domain | PDZ | 3.05e-03 | 151 | 74 | 4 | PS50106 | |
| Domain | PDZ | 3.12e-03 | 152 | 74 | 4 | IPR001478 | |
| Domain | IPT | 5.10e-03 | 27 | 74 | 2 | SM00429 | |
| Domain | PSI | 7.11e-03 | 32 | 74 | 2 | PF01437 | |
| Domain | IPT | 7.11e-03 | 32 | 74 | 2 | IPR002909 | |
| Domain | Plexin_repeat | 7.11e-03 | 32 | 74 | 2 | IPR002165 | |
| Pathway | REACTOME_LDL_REMODELING | 1.98e-04 | 6 | 52 | 2 | M42520 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS | 1.98e-04 | 6 | 52 | 2 | M27222 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.39e-04 | 33 | 52 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.39e-04 | 33 | 52 | 3 | MM14737 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 2.61e-04 | 34 | 52 | 3 | M27842 | |
| Pubmed | 2.28e-11 | 11 | 78 | 5 | 11483621 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 3.90e-11 | 12 | 78 | 5 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 3.90e-11 | 12 | 78 | 5 | 12215260 | |
| Pubmed | 3.50e-10 | 6 | 78 | 4 | 10588946 | ||
| Pubmed | Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. | 1.09e-08 | 3 | 78 | 3 | 9373263 | |
| Pubmed | 6.03e-07 | 8 | 78 | 3 | 17428193 | ||
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 32734583 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6B KMT2C MEGF8 NFKB2 RRP12 OSBPL5 POLRMT IRS2 PTCH1 CAMSAP1 SPEN ABCA7 BAHCC1 | 1.02e-06 | 1105 | 78 | 13 | 35748872 |
| Pubmed | The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. | 1.77e-06 | 11 | 78 | 3 | 25150496 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MTMR12 MAST4 MEGF8 NET1 USO1 OSBPL6 MAGI3 IRS2 GNAS CAMSAP1 WNK4 | 3.45e-06 | 861 | 78 | 11 | 36931259 |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24859635 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21404224 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11279184 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 4.97e-06 | 2 | 78 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 4.97e-06 | 2 | 78 | 2 | 23943648 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 4.97e-06 | 2 | 78 | 2 | 7705657 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23041318 | ||
| Pubmed | Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). | 4.97e-06 | 2 | 78 | 2 | 26975530 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19752236 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 6216475 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 4.97e-06 | 2 | 78 | 2 | 20440070 | |
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 4.97e-06 | 2 | 78 | 2 | 15456492 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25409527 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 8704243 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23702659 | ||
| Pubmed | Lipoprotein (a): impact by ethnicity and environmental and medical conditions. | 4.97e-06 | 2 | 78 | 2 | 26637279 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 4.97e-06 | 2 | 78 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 4.97e-06 | 2 | 78 | 2 | 9490683 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 26515419 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 16481742 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18983515 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34378815 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 4.97e-06 | 2 | 78 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 4.97e-06 | 2 | 78 | 2 | 21239499 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10642175 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12225871 | ||
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 4.97e-06 | 2 | 78 | 2 | 37971174 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 4.97e-06 | 2 | 78 | 2 | 26473342 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 4.97e-06 | 2 | 78 | 2 | 32694536 | |
| Pubmed | Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells. | 4.97e-06 | 2 | 78 | 2 | 9548923 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25614280 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 16103174 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21300353 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11306011 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12149246 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 4.97e-06 | 2 | 78 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 4.97e-06 | 2 | 78 | 2 | 21190118 | |
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 4.97e-06 | 2 | 78 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 4.97e-06 | 2 | 78 | 2 | 10885855 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 4.97e-06 | 2 | 78 | 2 | 12559391 | |
| Pubmed | Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a). | 4.97e-06 | 2 | 78 | 2 | 32630105 | |
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 4.97e-06 | 2 | 78 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 4.97e-06 | 2 | 78 | 2 | 16150044 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11916082 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 4.97e-06 | 2 | 78 | 2 | 11500461 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 4.97e-06 | 2 | 78 | 2 | 19683575 | |
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 4.97e-06 | 2 | 78 | 2 | 23555246 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18685433 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31462325 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35803063 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31690812 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30254165 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 4.97e-06 | 2 | 78 | 2 | 9819364 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 4.97e-06 | 2 | 78 | 2 | 18420257 | |
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 4.97e-06 | 2 | 78 | 2 | 18566672 | |
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 4.97e-06 | 2 | 78 | 2 | 20653841 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12428098 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24732409 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 4.97e-06 | 2 | 78 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 4.97e-06 | 2 | 78 | 2 | 16956791 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35045727 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15654123 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 1543918 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17267741 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 29990619 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17293777 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24972322 | ||
| Pubmed | The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction. | 4.97e-06 | 2 | 78 | 2 | 33423974 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 4.97e-06 | 2 | 78 | 2 | 10854210 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 4.97e-06 | 2 | 78 | 2 | 23527289 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9770530 | ||
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 4.97e-06 | 2 | 78 | 2 | 30323258 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24694356 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10816371 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34461734 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 4.97e-06 | 2 | 78 | 2 | 26791370 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 7525077 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 4.97e-06 | 2 | 78 | 2 | 16052596 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17122079 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15737740 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22056679 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18039665 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9671388 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27319402 | ||
| Interaction | KDM1B interactions | 2.45e-06 | 58 | 75 | 5 | int:KDM1B | |
| Interaction | TOP3B interactions | SEMA6B KMT2C MEGF8 SPTB NFKB2 RRP12 OSBPL5 POLRMT APOB IRS2 GNAS PTCH1 CAMSAP1 SPEN ABCA7 ARPC2 BAHCC1 | 2.18e-05 | 1470 | 75 | 17 | int:TOP3B |
| Cytoband | 10p15 | 5.95e-05 | 7 | 78 | 2 | 10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 3.37e-04 | 16 | 78 | 2 | chr6q26 | |
| Cytoband | 6q26 | 4.28e-04 | 18 | 78 | 2 | 6q26 | |
| Cytoband | 19q12 | 5.31e-04 | 20 | 78 | 2 | 19q12 | |
| Cytoband | 20q13.3 | 5.31e-04 | 20 | 78 | 2 | 20q13.3 | |
| Cytoband | Xp22.3 | 7.04e-04 | 23 | 78 | 2 | Xp22.3 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 9.25e-11 | 12 | 49 | 5 | 670 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.32e-04 | 206 | 49 | 5 | 682 | |
| GeneFamily | PDZ domain containing | 7.58e-04 | 152 | 49 | 4 | 1220 | |
| GeneFamily | Apolipoproteins | 1.46e-03 | 21 | 49 | 2 | 405 | |
| GeneFamily | Ankyrin repeat domain containing | 4.14e-03 | 242 | 49 | 4 | 403 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.75e-05 | 447 | 75 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | SHANK1 KMT2C ZNF536 OSBPL2 GSE1 MARK1 DENND4B PCDH11X IDS EBF4 ZIC1 | 4.86e-05 | 730 | 75 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SHANK1 ZNF536 OSBPL2 GSE1 MARK1 DENND4B NCAN ADGRG1 ZDBF2 IDS EBF4 ZIC1 | 6.46e-05 | 893 | 75 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.05e-04 | 212 | 75 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 177 | 77 | 6 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 192 | 77 | 6 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 192 | 77 | 6 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 148 | 77 | 5 | 5c853637f6058f78608ba0e76cda72a548d40710 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 148 | 77 | 5 | 763c598826445bf627989220cd7acd71c4f1ea36 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 148 | 77 | 5 | d3f224128593251b72429a1cd52e82f77df8e386 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 161 | 77 | 5 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 163 | 77 | 5 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 163 | 77 | 5 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 163 | 77 | 5 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-06 | 163 | 77 | 5 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.09e-05 | 168 | 77 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 168 | 77 | 5 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 168 | 77 | 5 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.18e-05 | 171 | 77 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 1.22e-05 | 172 | 77 | 5 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 174 | 77 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 174 | 77 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.32e-05 | 175 | 77 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.32e-05 | 175 | 77 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-05 | 176 | 77 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 183 | 77 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 77 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 183 | 77 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 183 | 77 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.69e-05 | 184 | 77 | 5 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.69e-05 | 184 | 77 | 5 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 185 | 77 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.78e-05 | 186 | 77 | 5 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.97e-05 | 190 | 77 | 5 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.23e-05 | 195 | 77 | 5 | 5de6841fa04f6fe6f0c2aa6c300667a25ae6d52e | |
| ToppCell | Healthy/Control-gd_T|Healthy/Control / Disease group and Cell class | 2.28e-05 | 196 | 77 | 5 | a6f9e55cd1cd7facadb3f508bded68023c997f3f | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.28e-05 | 196 | 77 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 2.28e-05 | 196 | 77 | 5 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | Healthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2) | 2.40e-05 | 198 | 77 | 5 | 25158815287efbdd8f463baa755cbb874f3905f3 | |
| ToppCell | Healthy_donor-gd_T|World / disease group, cell group and cell class (v2) | 2.40e-05 | 198 | 77 | 5 | 0c3475936f148f2c026501c61b43bcb94d320c48 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg|Bac-SEP / Disease, condition lineage and cell class | 2.46e-05 | 199 | 77 | 5 | e0b6136e28b813299b7ffbe37f1cf830e60cd7d8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 145 | 77 | 4 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 147 | 77 | 4 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-04 | 149 | 77 | 4 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | COVID-19_Severe-B_cell|World / disease group, cell group and cell class | 1.30e-04 | 149 | 77 | 4 | 9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 150 | 77 | 4 | ee2da4f684add821f2653d5db8eef46cd95c0fda | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 151 | 77 | 4 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 151 | 77 | 4 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 151 | 77 | 4 | 7758cfbe8dca849c90bd6e8bc63310e53beeb8fd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 151 | 77 | 4 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 151 | 77 | 4 | b4a0546c1573b4b2290890307f2a5daf3a7cbb37 | |
| ToppCell | droplet-Liver-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 152 | 77 | 4 | 1febeeb7376e34b9f86c81b2cb1314ee12408864 | |
| ToppCell | droplet-Liver-nan-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 152 | 77 | 4 | faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 152 | 77 | 4 | c21e2152b0130485659051d8fb7fb4589d1ec997 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 153 | 77 | 4 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | COVID-19_Severe-B_cell|COVID-19_Severe / disease group, cell group and cell class | 1.43e-04 | 153 | 77 | 4 | 701a7d92ee7b22277c8462742a530347cc6f061a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 154 | 77 | 4 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 157 | 77 | 4 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.61e-04 | 61 | 77 | 3 | 12de8c495c7f47ecd720f29a573471705603732a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.61e-04 | 61 | 77 | 3 | a655232c6d92335eb086723ab9b05eb3a5479b68 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 158 | 77 | 4 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 159 | 77 | 4 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 160 | 77 | 4 | 8de1fc75241d9bf2b355afa0e9ef39fea1977177 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 160 | 77 | 4 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 163 | 77 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.96e-04 | 166 | 77 | 4 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 167 | 77 | 4 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.10e-04 | 169 | 77 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.15e-04 | 170 | 77 | 4 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 170 | 77 | 4 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.15e-04 | 170 | 77 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.20e-04 | 171 | 77 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.20e-04 | 171 | 77 | 4 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Onecut2_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.23e-04 | 68 | 77 | 3 | 5af7170acc5e4503375d84472d538e7f5dc92e1d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 172 | 77 | 4 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 172 | 77 | 4 | a03f30a996a9474ad4cccd209476423a042df002 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 172 | 77 | 4 | f92a53ad2e464cd68ba1714bcc1d5911479cdf1c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 172 | 77 | 4 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-04 | 174 | 77 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 2.35e-04 | 174 | 77 | 4 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 175 | 77 | 4 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 2.45e-04 | 176 | 77 | 4 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-04 | 179 | 77 | 4 | 0b6731d9554f8bed1899c165a50e6b329ea19a6d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-04 | 180 | 77 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 181 | 77 | 4 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 181 | 77 | 4 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-04 | 182 | 77 | 4 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 2.84e-04 | 183 | 77 | 4 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-04 | 183 | 77 | 4 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-04 | 184 | 77 | 4 | b8ecf58b3bdb25bcba5efc2d764930bb84ab95c8 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 2.90e-04 | 184 | 77 | 4 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 2.90e-04 | 184 | 77 | 4 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.90e-04 | 184 | 77 | 4 | b232a9cc1d14e1a134b037016d437b93921a4a0f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.96e-04 | 185 | 77 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| Computational | Neighborhood of IGFBP1 | 1.26e-04 | 57 | 49 | 4 | CAR_IGFBP1 | |
| Computational | Neighborhood of HPX | 3.29e-04 | 73 | 49 | 4 | CAR_HPX | |
| Drug | sterol | 2.77e-07 | 265 | 77 | 9 | CID000001107 | |
| Drug | virus Tat | 2.78e-07 | 17 | 77 | 4 | CID000071655 | |
| Drug | Implanon | 5.32e-07 | 47 | 77 | 5 | CID000040976 | |
| Drug | AC1Q6PCP | 1.11e-06 | 230 | 77 | 8 | CID000005267 | |
| Drug | cortisone | 1.35e-06 | 103 | 77 | 6 | CID000222786 | |
| Drug | 17-isoprogesterone | OSBPL2 APOA5 USO1 LPA NFKB2 OSBPL5 OSBPL6 OSBPL11 APOB IRS2 GNAS PLG PTCH1 PZP NOS2 DIS3 | 1.50e-06 | 1170 | 77 | 16 | CID000004920 |
| Drug | E-guggulsterone | 1.79e-06 | 108 | 77 | 6 | CID006439929 | |
| Drug | CDRI-85/287 | 2.69e-06 | 29 | 77 | 4 | CID000159508 | |
| Drug | ethylnylestradiol | SCARF1 OSBPL2 APOA5 LPA NFKB2 OSBPL5 OSBPL6 OSBPL11 APOB WDR5 GNAS PLG IDS PTCH1 PZP NOS2 | 3.57e-06 | 1251 | 77 | 16 | CID000003285 |
| Drug | lynestrenol | 8.18e-06 | 38 | 77 | 4 | CID000005857 | |
| Drug | 2bqv | 1.13e-05 | 2 | 77 | 2 | CID005327090 | |
| Drug | 25-hydroxycholesterol | 1.72e-05 | 160 | 77 | 6 | CID000065094 | |
| Drug | Ro 16-6532 | 2.47e-05 | 50 | 77 | 4 | CID000122787 | |
| Drug | 4-hydroxy-3-nitrophenylacetyl (NP) caproic | 2.93e-05 | 18 | 77 | 3 | CID000444167 | |
| Drug | desogestrel | 3.01e-05 | 106 | 77 | 5 | CID000040973 | |
| Drug | magnesium fluoride | 3.12e-05 | 53 | 77 | 4 | CID000024546 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.14e-05 | 178 | 77 | 6 | 1112_DN | |
| Drug | homocysteine | 3.29e-05 | 266 | 77 | 7 | CID000000778 | |
| Drug | Aminocaproic Acid | 3.38e-05 | 3 | 77 | 2 | DB00513 | |
| Drug | menthol glucuronide | 3.38e-05 | 3 | 77 | 2 | CID000133208 | |
| Drug | CAS 93957-55-2 | 4.14e-05 | 187 | 77 | 6 | CID000003403 | |
| Drug | sodium molybdate | 4.17e-05 | 57 | 77 | 4 | CID000061424 | |
| Drug | pitavastatin | 4.27e-05 | 114 | 77 | 5 | CID005282451 | |
| Drug | epicholesterol | 5.49e-05 | 636 | 77 | 10 | CID000000304 | |
| Drug | NSC9564 | 7.00e-05 | 65 | 77 | 4 | CID000004536 | |
| Drug | Exosurf | 7.88e-05 | 67 | 77 | 4 | CID000071388 | |
| Drug | N-acetylcysteine | 9.31e-05 | 546 | 77 | 9 | CID000000581 | |
| Drug | sulfate | SCARF1 HGFAC MGMT LPA SPTB NCAN NFKB2 CD69 APOB WDR5 PLG IDS NOS2 DYNC1I2 | 9.74e-05 | 1292 | 77 | 14 | CID000001117 |
| Drug | AC1L1E7N | 1.02e-04 | 137 | 77 | 5 | CID000002676 | |
| Drug | 17alpha-estradiol | SCARF1 OSBPL2 APOA5 USO1 LPA NFKB2 OSBPL5 OSBPL6 OSBPL11 CD69 APOB IRS2 PZP NOS2 | 1.07e-04 | 1303 | 77 | 14 | CID000000450 |
| Drug | Sedalipid | 1.12e-04 | 5 | 77 | 2 | CID000173846 | |
| Drug | pipecolamide | 1.12e-04 | 5 | 77 | 2 | CID000140623 | |
| Drug | Advicor | 1.12e-04 | 5 | 77 | 2 | CID000151176 | |
| Drug | sulfite | 1.16e-04 | 438 | 77 | 8 | CID000001099 | |
| Drug | vitamin E | 1.22e-04 | 441 | 77 | 8 | CID000002116 | |
| Drug | H088 | 1.23e-04 | 75 | 77 | 4 | CID000004542 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.16e-09 | 42 | 76 | 6 | EFO_0022255 | |
| Disease | triglycerides in LDL measurement | 3.42e-07 | 56 | 76 | 5 | EFO_0022320 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.14e-07 | 110 | 76 | 6 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.14e-07 | 110 | 76 | 6 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides in small VLDL measurement | 5.27e-07 | 61 | 76 | 5 | EFO_0022145 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 5.45e-07 | 274 | 76 | 8 | EFO_0004530, EFO_0004612 | |
| Disease | triglycerides in small HDL measurement | 5.72e-07 | 62 | 76 | 5 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 5.72e-07 | 62 | 76 | 5 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 5.72e-07 | 62 | 76 | 5 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.72e-07 | 62 | 76 | 5 | EFO_0022339 | |
| Disease | triglycerides in small LDL measurement | 7.26e-07 | 65 | 76 | 5 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 7.84e-07 | 66 | 76 | 5 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 7.84e-07 | 66 | 76 | 5 | EFO_0022298 | |
| Disease | triglycerides to phosphoglycerides ratio | 9.11e-07 | 68 | 76 | 5 | EFO_0022327 | |
| Disease | cholesterol in very large HDL measurement | 9.80e-07 | 69 | 76 | 5 | EFO_0022229 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.06e-06 | 206 | 76 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | polyunsaturated fatty acid measurement | 1.16e-06 | 131 | 76 | 6 | EFO_0010733 | |
| Disease | very low density lipoprotein particle size measurement | 1.26e-06 | 133 | 76 | 6 | EFO_0008594 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.39e-06 | 74 | 76 | 5 | EFO_0022280 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.41e-06 | 215 | 76 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.65e-06 | 220 | 76 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.85e-06 | 224 | 76 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.85e-06 | 224 | 76 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | phospholipids:total lipids ratio | 2.03e-06 | 227 | 76 | 7 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.15e-06 | 229 | 76 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.18e-06 | 146 | 76 | 6 | EFO_0004530, EFO_0004639 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 2.52e-06 | 37 | 76 | 4 | EFO_0022252 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.85e-06 | 153 | 76 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.85e-06 | 153 | 76 | 6 | EFO_0004611, EFO_0020944 | |
| Disease | lipid measurement, lipoprotein measurement | 3.67e-06 | 90 | 76 | 5 | EFO_0004529, EFO_0004732 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 4.57e-06 | 166 | 76 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 4.80e-06 | 95 | 76 | 5 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement | 4.95e-06 | 260 | 76 | 7 | EFO_0008317 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.05e-06 | 96 | 76 | 5 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | high density lipoprotein particle size measurement | 5.24e-06 | 170 | 76 | 6 | EFO_0008592 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 6.48e-06 | 101 | 76 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 8.21e-06 | 106 | 76 | 5 | EFO_0008317, EFO_0008596 | |
| Disease | linoleic acid measurement | 8.77e-06 | 186 | 76 | 6 | EFO_0006807 | |
| Disease | cholesterol to total lipids in small HDL percentage | 9.26e-06 | 51 | 76 | 4 | EFO_0022240 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 9.40e-06 | 109 | 76 | 5 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 9.83e-06 | 110 | 76 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.03e-05 | 291 | 76 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides in HDL measurement | 1.08e-05 | 53 | 76 | 4 | EFO_0022317 | |
| Disease | triglycerides in medium HDL measurement | 1.17e-05 | 54 | 76 | 4 | EFO_0022321 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.22e-05 | 197 | 76 | 6 | EFO_0005680 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.33e-05 | 200 | 76 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.35e-05 | 56 | 76 | 4 | EFO_0022279 | |
| Disease | glycoprotein measurement | 1.44e-05 | 119 | 76 | 5 | EFO_0004555 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.90e-05 | 61 | 76 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.90e-05 | 126 | 76 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | free cholesterol in very large HDL measurement | 2.02e-05 | 62 | 76 | 4 | EFO_0022273 | |
| Disease | HETE measurement | 2.02e-05 | 62 | 76 | 4 | EFO_0801166 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.16e-05 | 63 | 76 | 4 | EFO_0022283 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.32e-05 | 330 | 76 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.58e-05 | 225 | 76 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | free cholesterol in large VLDL measurement | 2.92e-05 | 68 | 76 | 4 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 3.09e-05 | 69 | 76 | 4 | EFO_0022341 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.20e-05 | 24 | 76 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.20e-05 | 24 | 76 | 3 | C3805278 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 3.46e-05 | 71 | 76 | 4 | EFO_0022259 | |
| Disease | stomach cancer (is_implicated_in) | 3.66e-05 | 72 | 76 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.66e-05 | 72 | 76 | 4 | EFO_0022336 | |
| Disease | phospholipids in large HDL measurement | 3.87e-05 | 73 | 76 | 4 | EFO_0022190 | |
| Disease | total lipids in large HDL | 4.08e-05 | 74 | 76 | 4 | EFO_0022189 | |
| Disease | Cholangiocarcinoma | 4.09e-05 | 26 | 76 | 3 | C0206698 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 5.02e-05 | 78 | 76 | 4 | EFO_0022187 | |
| Disease | free cholesterol in large HDL measurement | 5.27e-05 | 79 | 76 | 4 | EFO_0022157 | |
| Disease | cholesteryl ester measurement | 5.41e-05 | 257 | 76 | 6 | EFO_0010351 | |
| Disease | cholesterol in large HDL measurement | 5.54e-05 | 80 | 76 | 4 | EFO_0021900 | |
| Disease | plasma plasminogen measurement | 6.51e-05 | 5 | 76 | 2 | EFO_0006309 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 6.51e-05 | 5 | 76 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 7.01e-05 | 31 | 76 | 3 | EFO_0022249 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 9.28e-05 | 34 | 76 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | angiostatin measurement | 9.75e-05 | 6 | 76 | 2 | EFO_0008024 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.27e-04 | 99 | 76 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 1.27e-04 | 99 | 76 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | fatty acid measurement | 1.33e-04 | 436 | 76 | 7 | EFO_0005110 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.33e-04 | 303 | 76 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | pancreatic cancer (is_marker_for) | 1.37e-04 | 101 | 76 | 4 | DOID:1793 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.43e-04 | 102 | 76 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.48e-04 | 103 | 76 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.51e-04 | 40 | 76 | 3 | EFO_0004746 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 1.51e-04 | 40 | 76 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.56e-04 | 312 | 76 | 6 | EFO_0004612, EFO_0010351 | |
| Disease | clinical treatment | 1.63e-04 | 41 | 76 | 3 | EFO_0007056 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.65e-04 | 315 | 76 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | metabolic syndrome | 1.70e-04 | 200 | 76 | 5 | EFO_0000195 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.75e-04 | 42 | 76 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.82e-04 | 321 | 76 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.88e-04 | 43 | 76 | 3 | DOID:9261 (is_marker_for) | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.88e-04 | 43 | 76 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.88e-04 | 43 | 76 | 3 | EFO_0022290 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.98e-04 | 111 | 76 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.16e-04 | 45 | 76 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Liver Diseases, Parasitic | 2.33e-04 | 9 | 76 | 2 | C0023897 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.50e-04 | 118 | 76 | 4 | EFO_0010119 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.75e-04 | 121 | 76 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.76e-04 | 222 | 76 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Pseudohypoaldosteronism, Type I | 2.91e-04 | 10 | 76 | 2 | C0268436 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHAPSRDPRDHQGSV | 41 | Q6ZR03 | |
| YIPSTQNPAFHHESR | 426 | Q8NDB2 | |
| RDPARHHPASFSVGN | 96 | Q5JWF8 | |
| TSEPVARAHSVAHAG | 1051 | Q9P281 | |
| ASHTAPQVLFSHREP | 191 | O15144 | |
| HSHPAAFEPSRQAAV | 606 | Q14687 | |
| VQELHRSVAPHAPAS | 206 | Q6Q788 | |
| STYQQAPRHFHVPDT | 411 | Q6H8Q1 | |
| AAQPQFVHPEHRSFV | 826 | O94985 | |
| VSSHVPSEAQPTHAQ | 2431 | Q12830 | |
| QPTPFALHHAASCEV | 471 | Q5T5Y3 | |
| HFHIAASINPATDIP | 356 | Q9Y485 | |
| VQHSSHRFSAPEVPA | 1311 | Q8IZY2 | |
| AQSPPASHAHLQVAA | 571 | P20742 | |
| FRIRFHDPSPAQSHT | 466 | Q7Z628 | |
| SPHFSTRHEGSFQVP | 26 | Q07108 | |
| VRNASGFHLPEDPSH | 961 | P35228 | |
| TALNHHVFPEAATPS | 201 | Q96DC9 | |
| VTPVTNQRHSDPYAH | 2191 | Q8NEZ4 | |
| PPSSHFASIFEESHV | 1131 | Q5TCQ9 | |
| QLVHQHPPAFEFTET | 461 | Q9C0I1 | |
| DVNPSARFVTVPLHH | 326 | Q16832 | |
| VPALHHPVFQQESFT | 81 | P16455 | |
| QRTPLSAAAHTHPVY | 371 | Q13409 | |
| DLSPAPAARHSHVAV | 271 | Q7Z7M0 | |
| VQATALHHSPPSAQA | 1226 | Q9BZA7 | |
| SEQVSHHPPISAFHA | 646 | Q9BXW6 | |
| AHCFSHSPPRDSVSV | 446 | Q04756 | |
| RFFSEQVSHHPPISA | 666 | Q9BZF3 | |
| AHPAVSRACSTPHVQ | 811 | O43182 | |
| VSPSFAHNPKRHNSA | 1161 | Q9Y4H2 | |
| NSVRATVQRYPPTHH | 66 | P23771 | |
| QVHASQPSSFHDFPD | 3601 | P04114 | |
| SHPHPAVVGINAFSS | 421 | Q9BQW3 | |
| HHSKPPTASQQEVRA | 106 | Q8NEG2 | |
| AAHLPAEFTPAVHAS | 111 | P69905 | |
| NAHHRSGAQVFPESP | 66 | O95467 | |
| SEEALTVHAPFPAAH | 61 | Q9Y653 | |
| FHSPPHTAAHNASVD | 161 | Q9Y653 | |
| AQEPHRHSTFIPGTN | 1746 | P08519 | |
| QRHTPQSPFTNHAAA | 436 | Q9BSJ5 | |
| PASPSHETGAFAHAR | 631 | Q9P0L2 | |
| SSAASASPHQPIVIH | 1131 | O15021 | |
| EAHISHFIHNVPFPS | 351 | O75064 | |
| VFHPGISSNHTDDSP | 136 | P22304 | |
| EHPQESTHEAFPASV | 3256 | Q8NDH2 | |
| THAEETPNQPFNSVH | 556 | Q86UP6 | |
| PSHEFQQVALHPART | 51 | Q52M75 | |
| NHTAHPSGVFSEQVP | 276 | P60507 | |
| RASDPAAYVSHLPVH | 906 | O00411 | |
| TVRFVAEQVSHHPPV | 501 | Q9BXB4 | |
| VSHHPPVSAFHVSNR | 476 | Q9H0X9 | |
| PIAVTHFLHNSANVP | 506 | O60763 | |
| SATHQFVHTFQSPEP | 346 | Q68DH5 | |
| VSAHQHPATARSPRA | 591 | O14841 | |
| HPTPISTEANRVEAH | 646 | O14594 | |
| NPVFAHSTVVHPESR | 1261 | Q13635 | |
| HQHPRTSEDTVGTFA | 781 | Q13796 | |
| FGHSVETPHIRAEPS | 176 | Q96LD1 | |
| AAQEPHRHSIFTPET | 506 | P00747 | |
| HRHSIFTPETNPRAG | 511 | P00747 | |
| EHDVPHQPFSQAVLS | 436 | Q9Y2L1 | |
| FISEQVSHHPPISAF | 171 | Q9H1P3 | |
| VSHHDPEVPFNHSFI | 496 | Q14162 | |
| LSPHFPHTAALDQAV | 521 | Q5JTH9 | |
| FATESSFDPHHRAQP | 856 | Q9Y566 | |
| PLPVSAASQAHQASH | 681 | Q99941 | |
| DVFIHQANHPLTVPS | 66 | Q8WZ69 | |
| HAPPAATLRRTHTFN | 836 | Q9H3T3 | |
| GHREPSAHPVEVFSF | 236 | Q9BSA9 | |
| HYHLPVARATAPVQS | 3161 | Q96T58 | |
| TPAVHSDFVSGVSPH | 741 | Q8IWN7 | |
| ASANPADHRVHQVTP | 191 | Q9GZP4 | |
| SHAPLHSVTNSPEVA | 876 | Q9HCK1 | |
| EAPVSHHAATERTSP | 2101 | P11277 | |
| AEPAEPHTHRTAEAQ | 3886 | Q96JG9 | |
| ALQANHSVPDVAHPV | 241 | O15090 | |
| VTSPRSEHYAAPQLH | 181 | Q15915 | |
| HRRTAHSPASATHPF | 291 | Q8TF50 | |
| TLPAHSDPVSAVHFN | 166 | P61964 | |
| PEADQHQPFLFRHAS | 561 | Q96J92 | |
| THRPHPTSICDNFSA | 291 | Q96GM8 | |
| VTHSDPPRAHAHSLV | 96 | Q00653 |